Miscellaneous
129
Topics
208
Posts
The responses, guidance, and advisories provided by the Pharmaceutical Advertising Advisory Board (PAAB),
including but not limited to those available through the PAAB Forum, the PAAB website, and any PAAB
correspondences, are specifically intended to assist individuals navigating the PAAB preclearance system.
Repurposing or reproducing this content without written consent from the PAAB Commissioner is strictly
prohibited. This prohibition includes, but is not limited to, use in machine learning or AI models.
-
442 - Hello there, I am a pharmacist from ON. I noticed some advertising from Mylan that I think is risky/dangerous and reckless in terms of the message it may be sending patients, the general public as well as pharmacists. I was wondering if I can make an anonymous complaint through this portal and in general what is the process for complaints? Details below. Mylan created a Fentanyl patch passport which is being distributed to patients who are dispensed Fentanyl by pharmacists. I have also seen it in airports on counters. The overall concept is good where they want patients to return their...
-
-
-
399 - We have an HCP-gated educational website/app containing endorsed medical education. We would like to post a program comprised of KOL-presented patient cases containing a video segment featuring one of that KOL's patients. What is the patient allowed to speak about on the video (e.g. their quality of life post-therapy...)?
-
-
-
-
-
-
-
-
-
-
-
341 - If 2 Files are received that have conflicting Reviewer comments (one favourable, one unfavourable), what is the recommended process for progressing both Files in terms of consistency Should we progress the favourable review, then cite that approval for the unfavourable review? Bringing the inconsistency to the attention of the Reviewers tends to lean towards a conservative outcome from the PAAB.
-
-
-
-
319 - I am confused on how Section 6.6vii is different from Consumer Brochures in "The distinction between advertising and other activities". The only differences I can think of is audience (patient vs. consumer), branding (branded vs. unbranded) and treatment discussion (no mention of treatment vs. objective discussion of all available treatments). Am I on the right track? Thanks!
-
